| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |